MedTrace Logo

The Efficacy of Trimethoprim in Wound Healing of Patients With Epidermolysis Bullosa

NCT00380640 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 10

Last updated 2018-04-19

No results posted yet for this study

Summary

The purpose of this study is to assess the efficacy of trimethoprim in promoting wound healing and decreasing blister formation in patients with Epidermolysis Bullosa.

Conditions

  • Epidermolysis Bullosa

Interventions

DRUG

Trimethoprim

This group will receive the active intervention (trimethoprim) first, followed by the placebo.

DRUG

Trimethoprim

This group will start the study with placebo, followed by the active intervention (trimethoprim).

Sponsors & Collaborators

  • The Hospital for Sick Children

    lead OTHER

Principal Investigators

  • Elena Pope, MD · The Hospital for Sick Children, Toronto Canada

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
CROSSOVER

Eligibility

Min Age
1 Day
Max Age
20 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-09-30
Primary Completion
2007-08-31
Completion
2007-09-30

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00380640 on ClinicalTrials.gov